Gypenoside XLIX
Cat. No. :YN290516
CAS No. :94987-08-3
86-020-82000279
sales@ubiochem.com
order@ubiochem.com| Product Name: | Gypenoside XLIX |
| CAS NO.: | 94987-08-3 |
| Chemical Name: | |
| Synonyms: | |
| Molecular Weight: | 1047.23 |
| Molecular Formula: | C₅₂H₈₆O₂₁ |
| SMILES: | O=C[C@@]([C@](CC1)([H])C2(C)C)(CC[C@@H]2O[C@@](OC[C@H](O)[C@@H]3O[C@@](OC[C@@H](O)[C@@H]4O)([H])[C@@H]4O)([H])[C@@H]3O[C@@](O[C@@H](C)[C@H](O)[C@H]5O)([H])[C@@H]5O)[C@](CC[C@@]6([H])[C@]7(CC[C@]6([H])[C@](CC/C=C(C)/C)(O)CO[C@@H]([C@@H]([C@@H](O)[C@@H]8O)O)O[C@@H]8CO)C)([H])[C@]71C |
| Storage: | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Transportation: | Room temperature in continental US; may vary elsewhere. |
| Description: | Gypenoside XLIX, a dammarane-type glycoside, is a prominent component ofG. pentaphyllum. Gypenoside XLIX is a selectiveperoxisome proliferator-activated receptor (PPAR)-alphaactivator and inhibits cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) overexpression and hyperactivity in human endothelial cells. |
| IC50&Target: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | |
| References: |
TELL : +86-020-82000279
Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.
